Crohn’s strictures open with anti-mycobacterial antibiotic therapy: A retrospective review

Table 1 Profile of the forty patients with Crohn’s disease presenting at pre-treatment

	Pre-treatment cohort (n = 40)
Demographics
Age at AMAT [yr (IQR)]	27 (24-39)
Sex [M (%)]	22 (55%)
Duration of disease [yr (IQR)]	3 (1-8)
Time between diagnosis and stricture [yr (IQR)]	2.5 (0-6)
Number of strictures
Single strictures, n (%)	34 (85)
Multiple strictures, n (%)	6 (15)
Symptoms
Y, n (%)	39 (98)
Abdominal pain, n (%)	31 (78)
Diarrhoea, n (%)	21 (53)
Fatigue, n (%)	6 (15)
Weight loss, n (%)	5 (13)
Vomiting, n (%)	4 (10)
Constipation, n (%)	2 (5)
Pathology
CRP [mg/L (IQR)]	19 (11-92)
ESR [mm/h (IQR)]	12 (5-27)
Area of involvement
ICV, n (%)	19 (48)
TI, n (%)	20 (50)
ICV + TI, n (%)	1 (3)
Concomitant medication
Y, n (%)	31 (78)
N, n (%)	9 (23)

AMAT: Anti-mycobacterial antibiotic therapy; IQR: Interquartile range; M: Male; Y: Yes; CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate; ICV: Ileocecal valve; TI: Terminal ileum; N: No.